The DOI matches its Crossref record; 420 of the 420 references it cites were found in a registry or an index.
Natural product and natural product derived drugs in clinical trials
Abstract
The 25 Natural Product (NP)-derived drugs launched since 2008 and the 100 NP-derived compounds and 33 Antibody Drug Conjugates (ADCs) in clinical trials or in registration at the end of 2013 are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Ranade, V. V. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31817c941f · Cited by 2,775
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Natural Products in Drug Discovery and Development
Cragg, G. M., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,585
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Self-citationThe role of vitamin D in reducing cancer risk and progression
Feldman, D., Krishnan, A. V., Swami, S., Giovannucci, E., & Feldman, B. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3691 · Cited by 1,311
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Osteosarcoma treatment – Where do we stand? A state of the art review
Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,234
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Türbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H. K., et al. (1999) · Science · doi:10.1126/science.285.5433.1573 · Cited by 1,173
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Self-citationFeling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
Ellouz, F., Adam, A., Ciorbaru, R., & Lederer, E. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90458-6 · Cited by 1,019
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
SEHGAL, S. N., BAKER, H., & VÉZINA, C. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.727 · Cited by 947
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Ehrenkranz, J. R. L., Lewis, N. G., Ronald Kahn, C., & Roth, J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.532 · Cited by 930
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
Chari, R. V. J., Miller, M. L., & Widdison, W. C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307628 · Cited by 930
Gölitz, P. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209858 · Cited by 922
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
SGLT2 inhibition — a novel strategy for diabetes treatment
Chao, E. C., & Henry, R. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3180 · Cited by 822
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
Pettit, G. R., Singh, S. B., Hamel, E., Lin, C. M., Alberts, D. S., & Garcia-Kendal, D. (1989) · Experientia · doi:10.1007/bf01954881 · Cited by 786
Antibody-Drug Conjugates in Cancer Therapy
Sievers, E. L., & Senter, P. D. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-201823 · Cited by 770
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
OMURA, S., IWAI, Y., HIRANO, A., NAKAGAWA, A., AWAYA, J., TSUCHIYA, H., TAKAHASHI, Y., & ASUMA, R. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.275 · Cited by 674
Isolation and structure of bryostatin 1
Pettit, G. R., Herald, C. L., Doubek, D. L., Herald, D. L., Arnold, E., & Clardy, J. (1982) · Journal of the American Chemical Society · doi:10.1021/ja00388a092 · Cited by 653
The impact of natural products upon modern drug discovery
Ganesan, A. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.016 · Cited by 646
Sin, N., Meng, L., Wang, M. Q. W., Wen, J. J., Bornmann, W. G., & Crews, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6099 · Cited by 635
Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701272q · Cited by 634
Natural Products As Sources for New Pesticides
Cantrell, C. L., Dayan, F. E., & Duke, S. O. (2012) · Journal of Natural Products · doi:10.1021/np300024u · Cited by 634
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Hamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.-R., Upeslacis, J., Shochat, D., et al. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010021y · Cited by 594
The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10
Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boettner, F. E., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B., & Bontems, R. J. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00256a070 · Cited by 583
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
FUJITA, T., INOUE, K., YAMAMOTO, S., IKUMOTO, T., SASAKI, S., TOYAMA, R., CHIBA, K., HOSHINO, Y., & OKUMOTO, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.208 · Cited by 540
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533
Halichondrins-antitumor polyether macrolides from a marine sponge
Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519
Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
Shu, Y.-Z. (1998) · Journal of Natural Products · doi:10.1021/np9800102 · Cited by 517
Höfle, G., Bedorf, N., Steinmetz, H., Schomburg, D., Gerth, K., & Reichenbach, H. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199615671 · Cited by 515
KAHAN, J. S., KAHAN, F. M., GOEGELMAN, R., CURRIE, S. A., JACKSON, M., STAPLEY, E. O., MILLER, T. W., MILLER, A. K., HENDLIN, D., MOCHALES, S., et al. (1979) · The Journal of Antibiotics · doi:10.7164/antibiotics.32.1 · Cited by 514
Fischer, T., Stone, R. M., DeAngelo, D. J., Galinsky, I., Estey, E., Lanza, C., Fox, E., Ehninger, G., Feldman, E. J., Schiller, G. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9678 · Cited by 504
Kupchan, S. M., Court, W. A., Dailey, R. G., Gilmore, C. J., & Bryan, R. F. (1972) · Journal of the American Chemical Society · doi:10.1021/ja00775a078 · Cited by 501
Rinehart, K. L., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F., Li, L. H., & Martin, D. G. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a007 · Cited by 492
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Self-citationUEDA, H., NAKAJIMA, H., HORI, Y., FUJITA, T., NISHIMURA, M., GOTO, T., & OKUHARA, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.301 · Cited by 489
FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor
Nakajima, H., Kim, Y. B., Terano, H., Yoshida, M., & Horinouchi, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4027 · Cited by 487
Towle, M. J., Salvato, K. A., Budrow, J., Wels, B. F., Kuznetsov, G., Aalfs, K. K., Welsh, S., Zheng, W., Seletsky, B. M., Palme, M. H., et al. (2001) · PubMed · Cited by 483
Vitamin D, disease and therapeutic opportunities
Plum, L. A., & DeLuca, H. F. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3318 · Cited by 477
Ingenol Mebutate Gel for Actinic Keratosis
Lebwohl, M., Swanson, N., Anderson, L. L., Melgaard, A., Xu, Z., & Berman, B. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111170 · Cited by 471
Schoner, W., & Scheiner-Bobis, G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00098.2007 · Cited by 456
Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J. (1998) · Science · doi:10.1126/science.282.5392.1324 · Cited by 440
Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus
Kupchan, S. M., Komoda, Y., Court, W. A., Thomas, G. J., Smith, R. M., Karim, A., Gilmore, C. J., Haltiwanger, R. C., & Bryan, R. F. (1972) · Journal of the American Chemical Society · doi:10.1021/ja00759a054 · Cited by 434
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4099 · Cited by 434
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Self-citationAn insight into the antifungal pipeline: selected new molecules and beyond
Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432
Griffith, E. C., Su, Z., Turk, B. E., Chen, S., Chang, Y.-H., Wu, Z., Biemann, K., & Liu, J. O. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90198-8 · Cited by 421
Drug discovery beyond the ‘rule-of-five’
Zhang, M.-Q., & Wilkinson, B. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.005 · Cited by 418
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
Levis, M., Ravandi, F., Wang, E. S., Baer, M. R., Perl, A., Coutre, S., Erba, H., Stuart, R. K., Baccarani, M., Cripe, L. D., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301796 · Cited by 398
Kung Sutherland, M. S., Walter, R. B., Jeffrey, S. C., Burke, P. J., Yu, C., Kostner, H., Stone, I., Ryan, M. C., Sussman, D., Lyon, R. P., et al. (2013) · Blood · doi:10.1182/blood-2013-03-491506 · Cited by 391
Asano, N., Yamashita, T., Yasuda, K., Ikeda, K., Kizu, H., Kameda, Y., Kato, A., Nash, R. J., Lee, H. S., & Ryu, K. S. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010567e · Cited by 390
Nomura, S., Sakamaki, S., Hongu, M., Kawanishi, E., Koga, Y., Sakamoto, T., Yamamoto, Y., Ueta, K., Kimata, H., Nakayama, K., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100332n · Cited by 385
Rüegger, A., Kuhn, M., Lichti, H., Loosli, H., Huguenin, R., Quiquerez, C., & von Wartburg, A. (1976) · Helvetica Chimica Acta · doi:10.1002/hlca.19760590412 · Cited by 384
Kuzuyama, T., Shimizu, T., Takahashi, S., & Seto, H. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01755-9 · Cited by 381
Luesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L., & Corbett, T. H. (2001) · Journal of Natural Products · doi:10.1021/np010049y · Cited by 378
Structure and synthesis of nojirimycin
Inouye, S., Tsuruoka, T., Ito, T., & Niida, T. (1968) · Tetrahedron · doi:10.1016/0040-4020(68)88115-3 · Cited by 377
Delves, M., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E., & Leroy, D. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001169 · Cited by 377
Sanchez, T., Estrada-Hernandez, T., Paik, J.-H., Wu, M.-T., Venkataraman, K., Brinkmann, V., Claffey, K., & Hla, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306896200 · Cited by 374
Charman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brun, R., Campbell, M., Charman, W. N., Chiu, F. C. K., Chollet, J., Craft, J. C., Creek, D. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015762108 · Cited by 373
Kumagai, H., Ebata, T., Takamori, K., Muramatsu, T., Nakamoto, H., & Suzuki, H. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp588 · Cited by 356
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2010) · Drugs · doi:10.2165/11534440-000000000-00000 · Cited by 352
Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275
Kaur, G., Stetler-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R., & Sausville, E. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.22.1736 · Cited by 346
Recent Developments in the Maytansinoid Antitumor Agents
Cassady, J. M., Chan, K. K., Floss, H. G., & Leistner, E. (2004) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.52.1 · Cited by 342
Zhanel, G. G., Chung, P., Adam, H., Zelenitsky, S., Denisuik, A., Schweizer, F., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Walkty, A., et al. (2014) · Drugs · doi:10.1007/s40265-013-0168-2 · Cited by 340
Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin
Imada, A., Kitano, K., Kintaka, K., Muroi, M., & Asai, M. (1981) · Nature · doi:10.1038/289590a0 · Cited by 335
SGLT inhibitors in management of diabetes
Tahrani, A. A., Barnett, A. H., & Bailey, C. J. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70050-0 · Cited by 332
Pettit, G. R., Singh, S. B., Niven, M. L., Hamel, E., & Schmidt, J. M. (1987) · Journal of Natural Products · doi:10.1021/np50049a016 · Cited by 328
Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase Inhibitors
Onishi, J., Meinz, M., Thompson, J., Curotto, J., Dreikorn, S., Rosenbach, M., Douglas, C., Abruzzo, G., Flattery, A., Kong, L., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.368-377.2000 · Cited by 326
Sparks, T. C., Crouse, G. D., & Durst, G. (2001) · Pest Management Science · doi:10.1002/ps.358 · Cited by 317
Ihle, N. T., Williams, R., Chow, S., Chew, W., Berggren, M. I., Paine-Murrieta, G., Minion, D. J., Halter, R. J., Wipf, P., Abraham, R., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.763.3.7 · Cited by 313
Groll, M., Huber, R., & Potts, B. C. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058320b · Cited by 312
Zhou, Z.-L., Yang, Y.-X., Ding, J., Li, Y.-C., & Miao, Z.-H. (2012) · Natural Product Reports · doi:10.1039/c2np00088a · Cited by 312
Piña, I. C., Gautschi, J. T., Wang, G.-Y.-S., Sanders, M. L., Schmitz, F. J., France, D., Cornell-Kennon, S., Sambucetti, L. C., Remiszewski, S. W., Perez, L. B., et al. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo034248t · Cited by 311
De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
Choi, S., Isaacs, A., Clements, D., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., & DeGrado, W. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811818106 · Cited by 308
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
Paugh, S. W., Payne, S. G., Barbour, S. E., Milstien, S., & Spiegel, S. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01168-2 · Cited by 302
Actinonin, a Naturally Occurring Antibacterial Agent, Is a Potent Deformylase Inhibitor
Chen, D. Z., Patel, D. V., Hackbarth, C. J., Wang, W., Dreyer, G. B., Young, D. C., Margolis, P. S., Wu, C., Ni, Z.-J., Trias, J., et al. (2000) · Biochemistry · doi:10.1021/bi992245y · Cited by 298
Maturing antibody–drug conjugate pipeline hits 30
Mullard, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4009 · Cited by 295
Soy isoflavones and prostate cancer: A review of molecular mechanisms
Mahmoud, A. M., Yang, W., & Bosland, M. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.12.010 · Cited by 281
Paeshuyse, J., Kaul, A., De Clercq, E., Rosenwirth, B., Dumont, J., Scalfaro, P., Bartenschlager, R., & Neyts, J. (2006) · Hepatology · doi:10.1002/hep.21102 · Cited by 279
N-containing sugars fromMorus alba and their glycosidase inhibitory activities
Asano, N., Oseki, K., Tomioka, E., Kizu, H., & Matsui, K. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)84060-1 · Cited by 275
Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase
Zgliczyński, J. M., Stelmaszyńska, T., Domański, J., & Ostrowski, W. (1971) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(71)90281-6 · Cited by 275
Zhou, H.-J., Aujay, M. A., Bennett, M. K., Dajee, M., Demo, S. D., Fang, Y., Ho, M. N., Jiang, J., Kirk, C. J., Laidig, G. J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801329v · Cited by 272
Chackalamannil, S., Wang, Y., Greenlee, W. J., Hu, Z., Xia, Y., Ahn, H.-S., Boykow, G., Hsieh, Y., Palamanda, J., Agans-Fantuzzi, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800180e · Cited by 269
A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
Chugh, R., Sangwan, V., Patil, S. P., Dudeja, V., Dawra, R. K., Banerjee, S., Schumacher, R. J., Blazar, B. R., Georg, G. I., Vickers, S. M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004334 · Cited by 268
McLaurin, J., Golomb, R., Jurewicz, A., Antel, J. P., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906994199 · Cited by 266
Ohtsu, H., Xiao, Z., Ishida, J., Nagai, M., Wang, H.-K., Itokawa, H., Su, C.-Y., Shih, C., Chiang, T., Chang, E., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020200g · Cited by 266
Girish, S., Gupta, M., Wang, B., Lu, D., Krop, I. E., Vogel, C. L., Burris III, H. A., LoRusso, P. M., Yi, J.-H., Saad, O., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1817-3 · Cited by 262
Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids
Álvarez, R., Vaz, B., Gronemeyer, H., & de Lera, Á. R. (2014) · Chemical Reviews · doi:10.1021/cr400126u · Cited by 260
SASSE, F., SIEINMETZ, H., HEIL, J., HÖFLE, G., & REICHENBACH, H. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.879 · Cited by 257
Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate
Rinehart, K. L., Gloer, J. B., Cook, J. C., Mizsak, S. A., & Scahill, T. A. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00397a055 · Cited by 256
Antitumor Activity of 3-Ingenyl Angelate
Ogbourne, S. M., Suhrbier, A., Jones, B., Cozzi, S.-J., Boyle, G. M., Morris, M., McAlpine, D., Johns, J., Scott, T. M., Sutherland, K. P., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2837 · Cited by 255
Industrial natural product chemistry for drug discovery and development
Bauer, A., & Brönstrup, M. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70058e · Cited by 255
(2023) · Advances in Pharmacology · doi:10.1016/s1054-3589(23)00038-8 · Cited by 251
Newman, D., & Cragg, G. (2014) · Marine Drugs · doi:10.3390/md12010255 · Cited by 250
Siemann, D. W., Chaplin, D. J., & Walicke, P. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802691068 · Cited by 250
C. Potts, B., X. Albitar, M., C. Anderson, K., Baritaki, S., Berkers, C., Bonavida, B., Chandra, J., Chauhan, D., C. Cusack, J., Fenical, W., et al. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519716 · Cited by 243
Zambrowicz, B., Freiman, J., Brown, P. M., Frazier, K. S., Turnage, A., Bronner, J., Ruff, D., Shadoan, M., Banks, P., Mseeh, F., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.58 · Cited by 243
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
Sutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Scheen, A. J. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0126-x · Cited by 234
Antibody‐Drug Conjugates for the Treatment of Cancer
Flygare, J. A., Pillow, T. H., & Aristoff, P. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12085 · Cited by 232
Photodynamic Effects of Novel XF Porphyrin Derivatives on Prokaryotic and Eukaryotic Cells
Maisch, T., Bosl, C., Szeimies, R.-M., Lehn, N., & Abels, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1542-1552.2005 · Cited by 232
Current drug research on PEGylation with small molecular agents
Li, W., Zhan, P., De Clercq, E., Lou, H., & Liu, X. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.07.006 · Cited by 232
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Willner, D., Trail, P. A., Hofstead, S. J., King, H. D., Lasch, S. J., Braslawsky, G. R., Greenfield, R. S., Kaneko, T., & Firestone, R. A. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00024a015 · Cited by 225
Shehzad, A., Lee, J., & Lee, Y. S. (2013) · BioFactors · doi:10.1002/biof.1068 · Cited by 224
Hebeisen, P., Heinze-Krauss, I., Angehrn, P., Hohl, P., Page, M. G. P., & Then, R. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.825-836.2001 · Cited by 219
Kiuchi, M., Adachi, K., Kohara, T., Minoguchi, M., Hanano, T., Aoki, Y., Mishina, T., Arita, M., Nakao, N., Ohtsuki, M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000173z · Cited by 217
Sugars with nitrogen in the ring isolated from the leaves of Morus bombycis
Asano, N., Tomioka, E., Kizu, H., & Matsui, K. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)80068-5 · Cited by 215
Crystal and Molecular Structure of an Iodo‐derivative of the Cyclic Undecapeptide Cyclosporin A
Petcher, T. J., Weber, H., & Rüegger, A. (1976) · Helvetica Chimica Acta · doi:10.1002/hlca.19760590509 · Cited by 214
Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
Katayama, R., Aoyama, A., Yamori, T., Qi, J., Oh-hara, T., Song, Y., Engelman, J. A., & Fujita, N. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3256 · Cited by 213
Epoxomicin, a new antitumor agent of microbial origin.
HANADA, M., SUGAWARA, K., KANETA, K., TODA, S., NISHIYAMA, Y., TOMITA, K., YAMAMOTO, H., KONISHI, M., & OKI, T. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1746 · Cited by 213
Chauhan, D., Singh, A. V., Aujay, M., Kirk, C. J., Bandi, M., Ciccarelli, B., Raje, N., Richardson, P., & Anderson, K. C. (2010) · Blood · doi:10.1182/blood-2010-04-276626 · Cited by 209
Miłobȩdzka, J., v. Kostanecki, S., & Lampe, V. (1910) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.191004302168 · Cited by 202
The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
Chatterji, U., Bobardt, M., Selvarajah, S., Yang, F., Tang, H., Sakamoto, N., Vuagniaux, G., Parkinson, T., & Gallay, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007625 · Cited by 202
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
Zhanel, G. G., Lawson, C. D., Zelenitsky, S., Findlay, B., Schweizer, F., Adam, H., Walkty, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.25 · Cited by 201
Deoxynojirimycin: synthesis and biological activity
Hughes, A. B., & Rudge, A. J. (1994) · Natural Product Reports · doi:10.1039/np9941100135 · Cited by 197
Discovery of a Structurally Novel Opioid .KAPPA.-Agonist Derived from 4,5-Epoxymorphinan.
NAGASE, H., HAYAKAWA, J., KAWAMURA, K., KAWAI, K., TAKEZAWA, Y., MATSUURA, H., TAJIMA, C., & ENDO, T. (1998) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.46.366 · Cited by 187
Bacterial Biosynthesis and Maturation of the Didemnin Anti-cancer Agents
Xu, Y., Kersten, R. D., Nam, S.-J., Lu, L., Al-Suwailem, A. M., Zheng, H., Fenical, W., Dorrestein, P. C., Moore, B. S., & Qian, P.-Y. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301735a · Cited by 186
Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.
COOPER, R. D. G., SNYDER, N. J., ZWEIFEL, M. J., STASZAK, M. A., WILKIE, S. C., NICAS, T. I., MULLEN, D. L., BUTLER, T. F., RODRIGUEZ, M. J., HUFF, B. E., et al. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.575 · Cited by 181
Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu, L.-C., Vetzel, M., Kleindl, P., Vlahov, I. R., & Leamon, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0033 · Cited by 176
Structures of harringtonine, isoharringtonine, and homoharringtonine
Powell, R. G., Weisleder, D., Smith, C. R., & Rohwedder, W. K. (1970) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)97839-6 · Cited by 175
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes
Kim, K. B., & Crews, C. M. (2013) · Natural Product Reports · doi:10.1039/c3np20126k · Cited by 175
Ohtake, Y., Sato, T., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Yamaguchi, M., Takami, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300884k · Cited by 174
Galsky, M. D., Dritselis, A., Kirkpatrick, P., & Oh, W. K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3254 · Cited by 173
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Pan, S., Gray, N. S., Gao, W., Mi, Y., Fan, Y., Wang, X., Tuntland, T., Che, J., Lefebvre, S., Chen, Y., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300396r · Cited by 171
Nathan, P., Zweifel, M., Padhani, A. R., Koh, D.-M., Ng, M., Collins, D. J., Harris, A., Carden, C., Smythe, J., Fisher, N., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3376 · Cited by 170
In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline
Macone, A. B., Caruso, B. K., Leahy, R. G., Donatelli, J., Weir, S., Draper, M. P., Tanaka, S. K., & Levy, S. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01242-13 · Cited by 170
Younes, A., Yasothan, U., & Kirkpatrick, P. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3629 · Cited by 170
Coenzyme Q10 as a therapy for mitochondrial disease
Hargreaves, I. P. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.01.020 · Cited by 169
A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
Isaksson, J., Brandsdal, B. O., Engqvist, M., Flaten, G. E., Svendsen, J. S. M., & Stensen, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200450h · Cited by 169
Origin, structure, and activity in vitro and in vivo of dalbavancin
Malabarba, A., & Goldstein, B. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki005 · Cited by 167
Romidepsin: a novel histone deacetylase inhibitor for cancer
Bertino, E. M., & Otterson, G. A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594437 · Cited by 166
Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)
LEADBETTER, M. R., ADAMS, S. M., BAZZINI, B., FATHEREE, P. R., KARR, D. E., KRAUSE, K. M., LAM, B. M. T., LINSELL, M. S., NODWELL, M. B., PACE, J. L., et al. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.326 · Cited by 165
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
Yang, Z., Chang, Y.-J., Yu, I.-C., Yeh, S., Wu, C.-C., Miyamoto, H., Merry, D. E., Sobue, G., Chen, L.-M., Chang, S.-S., et al. (2007) · Nature Medicine · doi:10.1038/nm1547 · Cited by 164
Leal, J., Martínez, M., García-Hernández, V., Moneo, V., Domingo, A., Bueren‐Calabuig, J. A., Negri, A., Gago, F., Guillen-Navarro, M. J., Avilés, P., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00945.x · Cited by 163
Macrocyclic ketone analogues of halichondrin B
Zheng, W., Seletsky, B. M., Palme, M. H., Lydon, P. J., Singer, L. A., Chase, C. E., Lemelin, C. A., Shen, Y., Davis, H., Tremblay, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.069 · Cited by 163
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic
Grossman, T. H., Starosta, A. L., Fyfe, C., O'Brien, W., Rothstein, D. M., Mikolajka, A., Wilson, D. N., & Sutcliffe, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06187-11 · Cited by 162
Paul, V. J., Frautschy, S., Fenical, W., & Nealson, K. H. (1981) · Journal of Chemical Ecology · doi:10.1007/bf00987707 · Cited by 162
Baggstrom, M. Q., Qi, Y., Koczywas, M., Argiris, A., Johnson, E. A., Millward, M. J., Murphy, S. C., Erlichman, C., Rudin, C. M., & Govindan, R. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822e2941 · Cited by 161
Kakinuma, H., Oi, T., Hashimoto-Tsuchiya, Y., Arai, M., Kawakita, Y., Fukasawa, Y., Iida, I., Hagima, N., Takeuchi, H., Chino, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901893x · Cited by 159
New Lead Structures in Antifungal Drug Discovery
Sheng, C., & Zhang, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794480113 · Cited by 159
Mechanism of Action of the Novel Aminomethylcycline Antibiotic Omadacycline
Draper, M. P., Weir, S., Macone, A., Donatelli, J., Trieber, C. A., Tanaka, S. K., & Levy, S. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01066-13 · Cited by 158
Tetrodotoxin (TTX) as a Therapeutic Agent for Pain
Nieto, F. R., Cobos, E. J., Tejada, M. A., Sánchez–Fernández, C., González‐Cano, R., & Cendán, C. M. (2012) · Marine Drugs · doi:10.3390/md10020281 · Cited by 157
Peláez, F., Cabello, A., Platas, G., Dı́ez, M. T., del Val, A. G., Basilio, Á., Martán, I., Vicente, F., Bills, G. F., GIACOBBE, R. A., et al. (2000) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(00)80062-4 · Cited by 156
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
Bose, P., Simmons, G. L., & Grant, S. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.789859 · Cited by 154
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
Gin, A. S., Dilay, L., Karlowsky, J. A., Walkty, A. J., Rubinstein, E., & Zhanel, G. G. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.3.365 · Cited by 153
Zhang, B., Watts, K. M., Hodge, D. M., Kemp, L. M., Hunstad, D. A., Hicks, L. M., & John, A. R. O. (2011) · Biochemistry · doi:10.1021/bi200113y · Cited by 152
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid
Kruczynski, A., Barret, J.-M. M., Etiévant, C., Colpaert, F. C., Fahy, J., & Hill, B. T. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00505-4 · Cited by 149
Pyridorin in Type 2 Diabetic Nephropathy
Lewis, E. J., Greene, T., Spitalewiz, S., Blumenthal, S. S., Berl, T., Hunsicker, L. G., Pohl, M. A., Rohde, R. D., Raz, I., Yerushalmy, Y., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011030272 · Cited by 148
Chemical modification of rapamycin: the discovery of SDZ RAD
Sedrani, R. C., Cottens, S., Kallen, J. A., & Schüler, W. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)00587-9 · Cited by 147
Kantarjian, H. M., O'Brien, S. M., & Cortes, J. E. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.03.017 · Cited by 146
Natural products and Pharma 2011: Strategic changes spur new opportunities
Carter, G. T. (2011) · Natural Product Reports · doi:10.1039/c1np00033k · Cited by 144
Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
Rowe, J. M., & Löwenberg, B. (2013) · Blood · doi:10.1182/blood-2013-03-490482 · Cited by 143
Flynn, B. L., Gill, G. S., Grobelny, D. W., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200454y · Cited by 143
Urdiales, J. L., Morata, P., de Castro, I. N., & Sánchez‐Jiménez, F. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04151-1 · Cited by 142
Eathiraj, S., Palma, R., Volckova, E., Hirschi, M., France, D. S., Ashwell, M. A., & Chan, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213801 · Cited by 140
OKUHARA, M., Kuroda, Y., Goto, T., Okamoto, M., Terano, H., KOHSAKA, M., AOKI, H., & Imanaka, H. (1980) · The Journal of Antibiotics · doi:10.7164/antibiotics.33.24 · Cited by 140
In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa
Takeda, S., Nakai, T., Wakai, Y., Ikeda, F., & Hatano, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-06 · Cited by 140
Ishikawa, T., Matsunaga, N., TAWADA, H., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00126-3 · Cited by 140
Imamura, M., Nakanishi, K., Suzuki, T., Ikegai, K., Shiraki, R., Ogiyama, T., Murakami, T., Kurosaki, E., Noda, A., Kobayashi, Y., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.051 · Cited by 139
Hopkins, S., Scorneaux, B., Huang, Z., Murray, M. G., Wring, S. A., Smitley, C., Harris, R. W., Erdmann, F., Fischer, G. S., & Ribeill, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00660-09 · Cited by 139
In Vitro and In Vivo Synergy of Fosmidomycin, a Novel Antimalarial Drug, with Clindamycin
Wiesner, J., Henschker, D., Hutchinson, D. B., Beck, E., & Jomaa, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2889-2894.2002 · Cited by 138
Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
Meyers, P. A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.69 · Cited by 134
Shigematsu, N., Ueda, H., Takase, S., Tanaka, H., Yamamoto, K., & TADA, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.311 · Cited by 134
Wagner, J., von Matt, P., Sedrani, R. C., Albert, R., Cooke, N. G., Ehrhardt, C., Geiser, M., Rummel, G., Stark, W., Strauss, A., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901108b · Cited by 132
Leimgruber, W., Batcho, A. D., & Schenker, F. (1965) · Journal of the American Chemical Society · doi:10.1021/ja00952a051 · Cited by 132
Active‐site‐specific chaperone therapy for Fabry disease
Fan, J., & Ishii, S. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06041.x · Cited by 131
Remiszewski, S., Sambucetti, L. C., Bair, K. W., Bontempo, J., Cesarz, D., Chandramouli, N., Chen, R., Cheung, M., Cornell-Kennon, S., Dean, K., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030235w · Cited by 130
Second generation S1P pathway modulators: Research strategies and clinical developments
Bigaud, M., Guerini, D., Billich, A., Bassilana, F., & Brinkmann, V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.001 · Cited by 129
Vlahov, I. R., Santhapuram, H. K. R., Kleindl, P. J., Howard, S. J., Stanford, K., & Leamon, C. P. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.030 · Cited by 128
A83543A-D, unique fermentation-derived tetracyclic macrolides
Kirst, H. A., Michel, K. H., Martin, J. W., Creemer, L. C., Chio, E. H., YAO, R. C., Nakatsukasa, W. M., Boeck, L. D., Occolowitz, J. L., Paschal, J. W., et al. (1991) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)93474-9 · Cited by 128
Pneumocandins from Zalerion arboricola. I. Discovery and isolation.
Schwartz, R. E., Sesin, D. F., JOSHUA, H., et al. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1853 · Cited by 127
Welslau, M., Diéras, V., Sohn, J., Hurvitz, S. A., Lalla, D., Fang, L., Althaus, B., Guardino, E., & Miles, D. (2014) · Cancer · doi:10.1002/cncr.28465 · Cited by 126
Ascher, B., Hoffmann, K. K. P., Walker, P., Lippert, S., Wollina, U., & Havlíčková, B. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12377 · Cited by 126
Bryostatins: biological context and biotechnological prospects
Silva, A. E. T., Lim‐Fong, G., Sharp, K. H., & Haygood, M. G. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.018 · Cited by 126
Rzany, B., Griffiths, T. W., Walker, P., Lippert, S., McDiarmid, J., & Havlíčková, B. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12695 · Cited by 126
Xiao, X.-Y., Hunt, D. K., Zhou, J., Clark, R. B., Dunwoody, N., Fyfe, C., Grossman, T. H., O’Brien, W. J., Plamondon, L., Rönn, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201465w · Cited by 126
From natural products to clinically useful antifungals
Barrett, D. G. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00085-6 · Cited by 126
Jiménez‐Ortigosa, C., Paderu, P., Motyl, M. R., & Perlin, D. S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02145-13 · Cited by 123
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
The molecular mystique of tetrodotoxin
Moczydlowski, E. G. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.11.026 · Cited by 122
Cited by
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
Natural product discovery: past, present, and future
Katz, L., & Baltz, R. H. (2016) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-015-1723-5 · Cited by 1,144
Anand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019) · Metabolites · doi:10.3390/metabo9110258 · Cited by 867
Metadata
- Authors
- Butler, M. S., Robertson, A. A. B., & Cooper, M. A.
- Venue
- Nat. Prod. Rep.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 31
- Issue
- 11
- Pages
- 1612-1661
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2088629793
- Cited by
- 602
- References
- 420
- FWCI
- 36.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.